New York
(New York, NY -- July 12, 2009) -- Researchers at Mount Sinai School of Medicine have found that a compound called NIC5-15, might be a safe and effective treatment to stabilize cognitive performance in patients with mild to moderate Alzheimer's disease. The two investigators, Giulio Maria Pasinetti, M.D., Ph.D.
NEW YORK (July 8, 2009) -- A new finding reveals that African-American patients with breast, ovarian, and prostate cancer tend to die earlier than patients of other races with these cancers, even when they receive identical medical treatment and when socioeconomic factors are controlled for.
MAYWOOD -- Adverse work conditions may be to blame for the decline in the number of primary care physicians nationwide, according to a study published in the latest issue of the Annals of Internal Medicine.
U.S. municipal governments are showing leadership by voluntarily accounting for and reducing greenhouse gas emissions resulting from their operations. They also recognize the huge potential to influence long-term reductions from the residents and businesses in their communities, according to a new report.
An international collaboration of 390 scientists reports the discovery of an outburst of very-high-energy (VHE) gamma radiation from the giant radio galaxy Messier 87 (M 87), accompanied by a strong rise of the radio flux measured from the direct vicinity of its super-massive black hole.
Prostate cancer patients who receive brachytherapy and remain free of disease for five years or greater are unlikely to have a recurrence at 10 years, according to a study in the July 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO).
Brachytherapy is the placement of radioactive sou
NEW YORK, JULY 2, 2009 -- A new study by researchers at Memorial Sloan-Kettering Cancer Center (MSKCC) reveals the genetic underpinnings of what causes lung cancer to quickly metastasize, or spread, to the brain and the bone -- the two most prominent sites of lung cancer relapse. The study will be published online in the journal Cell on July 2.
A new neuropsychological memory test is helping to uncover how Parkinson's disease can alter people's ability to learn about the consequences of the choices they make. The test was developed by Dr.
EVANSTON, Ill. --- To many, New York Gov. Eliott Spitzer's fall from grace seemed to make no sense at all. But a new Northwestern University study offers provocative insights that possibly could relate to why the storm trooper of reform -- formerly known as the Sheriff of Wall Street -- seemingly went from saint to sinner overnight.
New York, June 25, 2009 -- A protein called STAT3 has been found to play a fundamental role in converting normal cells to cancerous cells, according to a new study led by David E. Levy, Ph.D., professor of pathology and microbiology at NYU Langone Medical Center.
In the mating world of yellow dung flies, large, brawny males almost always get the girl. However, a new study suggests that smaller males rule if presented with an opportunity to woo females when they are not hanging out on cow dung. It is the first time alternative male reproductive strategies have been observed in this species.
Cold Spring Harbor, N.Y. -- A math-based game that has taken the world by storm with its ability to delight and puzzle may now be poised to revolutionize the fast-changing world of genome sequencing and the field of medical genetics, suggests a new report by a team of scientists at Cold Spring Harbor Laboratory (CSHL).
A landmark study has successfully demonstrated a 29 percent reduction in heart failure or death in patients with heart disease who received an implanted cardiac resynchronization therapy device with defibrillator (CRT-D) versus patients who received only an implanted cardiac defibrillator (ICD-only).
NEW YORK (June 22, 2009) -- New research shows that physicians failed to report clinically significant abnormal test results to patients -- or to document that they had informed them -- in one out of every 14 cases of abnormal results. In some medical groups, the failure rate is close to zero; in others it is as high as one in four abnormal results.
Four percent of all children suffer from amblyopia, better known as "lazy eye syndrome." Traditional treatment for the condition requires the use of an eye patch, often for months at a time, before the eye is corrected. This can lead to social stigma during a formative part of childhood, and worse, it's not 100% effective.
